Virginia Tech Carilion Research Institute scientists take first-of-kind dopamine readings in humans
Virginia Tech Carilion Research Institute scientists have reported measurements of dopamine release with unprecedented temporal precision in the brains of people with Parkinson’s disease.
Virginia Tech Carilion Research Institute scientists gain insight into cause of Alzheimer’s symptoms
Virginia Tech Carilion Research Institute scientists have uncovered a mechanism in the brain that could account for some of the neural degeneration and memory loss in people with Alzheimer’s disease. The researchers, together with scientists at the University of Alabama at Birmingham School of Medicine, discovered that a common symptom of Alzheimer’s disease – the accumulation of amyloid plaques along blood vessels – could be disrupting blood flow in the brain. The results were published in the journal Brain.
Virginia Tech Carilion receives Excellence in Virginia Government Award
The Virginia Tech Carilion School of Medicine and Research Institute recently received one of seven Excellence in Virginia Government Awards given annually by the L. Douglas Wilder School of Government and Public Affairs at Virginia Commonwealth University. The organization was recognized for its successful public-private partnership.
Scientists awarded $2.4 million to research potential behavioral treatment in prediabetic individuals
Warren Bickel, a professor at the Virginia Tech Carilion Research Institute, recently received a $2.4 million grant to investigate and improve maladaptive decision-making that may contribute to Type 2 diabetes.
Nobel Laureate to kick off Virginia Tech Carilion Research Institute’s public lecture series
Modeling human disease, extending the average human lifespan to a century, unlocking clues to brain plasticity – these intriguing propositions signal the start of the sixth annual season of the Virginia Tech Carilion Research Institute’s Distinguished Public Lecture Series.
Scientists find a small tweak could make a big difference in immune cells
Scientists at the Virginia Tech Carilion Research Institute have discovered even a small shift in environmental factors can change how a cell in the immune system matures.
Scientists unexpectedly find ALS affects sensory neurons involved in movement
Researchers discover neurons affected by ALS that could help speed the identification and testing of therapeutics.
Neuroscience experts bring “The Brain State” research to the public
An alliance of researchers are endeavoring to make Virginia the hub of scientific efforts to understand and develop treatments for brain-related disorders ranging from Alzheimer’s disease to addiction and brain tumors. Members of the public were recently invited to hear about the latest research conducted in “The Brain State” at a panel called Dissecting Science: Your Amazing Brain.
‘Brainbow’ reveals surprising data about visual connections in brain
Neuroscientists know that some connections in the brain are pruned through neural development. Function gives rise to structure, according to the textbooks. But scientists at the Virginia Tech Carilion Research Institute have discovered that the textbooks might be wrong.
Scientists develop new toolkit to examine molecular mechanisms of human disease
Virginia Tech Carilion Research Institute scientist Deborah Kelly and her research team developed a tunable microchip to view activity inside a human breast cancer cell for the first time.
From the Executive Director
Since opening its doors in September 2010, the Virginia Tech Carilion Research Institute has drawn 21 world-class research teams to Roanoke, Virginia. These teams are led by scientists who transcend conventional disciplinary boundaries as they seek innovation and discovery in the service of health.
- Stephen LaConte promoted to associate professor
- Michael Fox named 2015 NARSAD Independent Investigator
- Pearl Chiu presented to the National Institutes of Mental Health advisory council
- Roanoke Times (Nov 20): Virginia Tech-Carilion lecture series offers cutting-edge science for non-scientists
- Targeted Oncology (Nov 20): Scientists uncover potential TMZ resistance reversal in glioblastoma
- WVTF (Nov 16): Glioblastoma canine clinical trials